Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study

Microbiome connections with host metabolism and habitual diet from 1,098 deeply phenotyped individuals

(2021) Francesco Asnicar et al.   NATURE MEDICINE

Cardiovascular disease in diabetes, beyond glucose

(2021) Robert H. Eckel et al.   Cell Metabolism

Fermentation Products of Commensal Bacteria Alter Enterocyte Lipid Metabolism

(2020) João R. Araújo et al.   Cell Host & Microbe

A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors

(2020) Ina Nemet et al.   CELL

Cholesterol Metabolism by Uncultured Human Gut Bacteria Influences Host Cholesterol Level

(2020) Douglas J. Kenny et al.   Cell Host & Microbe

Gut Microbiota and Cardiovascular Disease

(2020) Marco Witkowski et al.   CIRCULATION RESEARCH

Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study

(2019) Massimiliano Ruscica et al.   Nutrition Journal

1,520 reference genomes from cultivated human gut bacteria enable functional microbiome analyses

(2019) Yuanqiang Zou et al.   NATURE BIOTECHNOLOGY

Urinary bisphenol A concentration and glucose homeostasis in non-diabetic adults: a repeated-measures, longitudinal study

(2019) Bin Wang et al.   DIABETOLOGIA

Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank

(2019) Claire Welsh et al.   CIRCULATION

Understanding the Role of the Gut Microbiome and Microbial Metabolites in Obesity and Obesity-Associated Metabolic Disorders: Current Evidence and Perspectives

(2019) Natalia Vallianou et al.   Current Obesity Reports

A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption

(2019) Hye Rim Jang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

The intestinal microbiota programs diurnal rhythms in host metabolism through histone deacetylase 3

(2019) Zheng Kuang et al.   SCIENCE

Atorvastatin Targets the Islet Mevalonate Pathway to Dysregulate mTOR Signaling and Reduce β-Cell Functional Mass

(2019) Linyan Shen et al.   DIABETES

Comprehensive Strategy to Construct In-House Database for Accurate and Batch Identification of Small Molecular Metabolites

(2018) Xinjie Zhao et al.   ANALYTICAL CHEMISTRY

Small Intestine Microbiota Regulate Host Digestive and Absorptive Adaptive Responses to Dietary Lipids

(2018) Kristina Martinez-Guryn et al.   Cell Host & Microbe

A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma

(2018) Ping Luo et al.   HEPATOLOGY

Role of Bile Acids in Metabolic Control

(2018) Antonio Molinaro et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Ion-Pair Selection Method for Pseudotargeted Metabolomics Based on SWATH MS Acquisition and Its Application in Differential Metabolite Discovery of Type 2 Diabetes

(2018) Lichao Wang et al.   ANALYTICAL CHEMISTRY

Nonfasting versus fasting lipid profile for cardiovascular risk prediction

(2018) Anne Langsted et al.   PATHOLOGY

Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention

(2017) Ruixin Liu et al.   NATURE MEDICINE

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

(2017) Arrigo F G Cicero et al.   NUTRITION REVIEWS

Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment

(2017) Yanyun Gu et al.   Nature Communications

Nonfasting Triglycerides, Low-Density Lipoprotein Cholesterol, and Heart Failure Risk

(2017) Anette Varbo et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive MiceClinical Perspective

(2016) Francine Z. Marques et al.   CIRCULATION

Clinical Update: Cardiovascular Disease in Diabetes Mellitus

(2016) Cecilia C. Low Wang et al.   CIRCULATION

Gut microbiome and lipid metabolism

(2016) Zheng Wang et al.   CURRENT OPINION IN LIPIDOLOGY

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Lipid-modifying effects of nutraceuticals: An evidence-based approach

(2016) Amirhossein Sahebkar et al.   NUTRITION

Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies

(2015) Angela Pirillo et al.   ATHEROSCLEROSIS

Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life

(2015) Fredrik Bäckhed et al.   Cell Host & Microbe

Reply to Letters Regarding Article, “Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality: Insight From the National Health and Nutrition Examination Survey III (NHANES-III)”

(2015) Bethany Doran et al.   CIRCULATION

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

(2015) Larry M. Baddour et al.   CIRCULATION

The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood LipidsNovelty and Significance

(2015) Jingyuan Fu et al.   CIRCULATION RESEARCH

The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial

(2015) K.L. Ivey et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

A new model of reverse cholesterol transport: enTICEing strategies to stimulate intestinal cholesterol excretion

(2015) Ryan E. Temel et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Postprandial glucose, insulin and incretin responses to different carbohydrate tolerance tests

(2015) Yuying Deng et al.   Journal of Diabetes

New and emerging regulators of intestinal lipoprotein secretion

(2014) Changting Xiao et al.   ATHEROSCLEROSIS

Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality

(2014) Bethany Doran et al.   CIRCULATION

LDL Cholesterol as a Predictor of Mortality, and Beyond

(2014) Robert H. Eckel   CIRCULATION

Probiotics and the BSH-related cholesterol lowering mechanism: a Jekyll and Hyde scenario

(2014) Sy-Bing Choi et al.   CRITICAL REVIEWS IN BIOTECHNOLOGY

Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery

(2014) Yaping Shao et al.   JOURNAL OF PROTEOME RESEARCH

Bifidobacteria supplementation: Effects on plasma lipid profiles in dyslipidemic children

(2014) Ornella Guardamagna et al.   NUTRITION

Berberine activates thermogenesis in white and brown adipose tissue

(2014) Zhiguo Zhang et al.   Nature Communications

Clinical Considerations and Mechanistic Determinants of Postprandial Lipemia in Older Adults

(2014) Christos S. Katsanos   Advances in Nutrition

Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteria

(2013) Alessandra Bordoni et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Transintestinal Cholesterol Excretion Is an Active Metabolic Process Modulated by PCSK9 and Statin Involving ABCB1

(2013) Cédric Le May et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

(2013) David C. Goff et al.   CIRCULATION

HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment

(2013) et al.   EUROPEAN HEART JOURNAL

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

(2013) W.H. Wilson Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats

(2012) Xu Zhang et al.   PLoS One

Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes

(2011) Lutgarda Bozzetto et al.   ATHEROSCLEROSIS

Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats

(2010) Y.-T. Liu et al.   DRUG METABOLISM AND DISPOSITION

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

(2010) The Emerging Risk Factors Collaboration   LANCET

The gut microbiota modulates host energy and lipid metabolism in mice

(2009) Vidya R. Velagapudi et al.   JOURNAL OF LIPID RESEARCH

Multivariate paired data analysis: multilevel PLSDA versus OPLSDA

(2009) Johan A. Westerhuis et al.   Metabolomics

Intestinal lipoprotein overproduction in insulin-resistant states

(2008) Khosrow Adeli et al.   CURRENT OPINION IN LIPIDOLOGY

Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine

(2008) Yifei Zhang et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE